Scar
Conditions
Interventions
Experimental group:Tension reduction
Control Group:Without tension reduction
Sponsors
Shanghai Ninth People's Hospital, Shanghai Jiaotong University School Of Medicine
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Aged 6-40 years; 2. Incision length exceeds (includes) 6cm; 3. Skin type III/IV; 4. Patients with large-area body surface masses on the head and face in the first stage of operation, including congenital giant melanin nevus, residual hemangioma lesions in infants in the large-area regression stage, and arteriovenous malformations on the head and face, etc.
Exclusion criteria
Exclusion criteria: 1. Tensioner is not suitable for facial surgery areas, such as the nose, side of the nose, upper eyelid, eyebrow and ear; 2. Have a history of keloid, or a family history of keloid; 3. Severe skin diseases, such as psoriasis, scleroderma, etc.; 4. With clinical manifestations of obvious or unstable systemic disease, based on May cause interference to the results of safety indicators shall be excluded, including malignant tumors, is difficult to control high blood pressure, diabetes, is difficult to control instability and organic pneumonia, kidney or liver disease, unstable myocardial ischemic diseases, expansionary myocardial disease, cardiac conduction disorders or instability of cardiovascular disease, etc.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Scar Width; | — |
Secondary
| Measure | Time frame |
|---|---|
| Rate of Hypertrophy Scar ;Skin Visia;Patient and Observer Scar Assessment Scale (POSAS) Score; | — |
Countries
China
Contacts
Public ContactXiao-Xi Lin
Shanghai Ninth People's Hospital, Shanghai Jiaotong University School Of Medicine
Outcome results
None listed